发明名称 |
CONTROLLED RELEASED CARVEDIOLOL FORMULATION |
摘要 |
A CONTROLLED RELEASE CARVEDILOL FORMULATION FOR LESS FREQUENT, PREFERABLY ONCE DAILY ADMINISTRATION IS DESCRIBED. THE CONTROLLED RELEASE FORMULATION COMPRISES A THERAPEUTICALLY EFFECTIVE AMOUNT OF CARVEDILOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A MATRIX FORMING POLYMER, A SOLUBILITY ENHANCER AND A PHARMACEUTICALLY ACCEPTABLE CARRIER. IN ONE EMBODIMENT, A CONTROLLED RELEASE FORMULATION HAVING A THERAPEUTICALLY EFFECTIVE AMOUNT OF CARVEDILOL IS CONTAINED IN TWO OR MORE SUBUNITS HAVING DIFFERENT RELEASE PROFILES. THE CONTROLLED RELEASE FORMULATION IS USABLE IN THE TREATMENT AND/OR PROPHYLAXIS OF ONE OR MORE CONDITIONS SUCH AS CARDIOVASCULAR DISORDERS. |
申请公布号 |
MY157299(A) |
申请公布日期 |
2016.05.31 |
申请号 |
MY2012PI01433 |
申请日期 |
2010.09.29 |
申请人 |
TSH BIOPHARM CORPORATION LTD.;INNOPHARMAX, INC. |
发明人 |
HAO, WEI-HUA;LIN, TSUNG-HSIN;LV, TA-CHIEN |
分类号 |
A61K9/20 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|